Correlation Between Mydecine Innovations and Green Thumb

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Mydecine Innovations and Green Thumb at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mydecine Innovations and Green Thumb into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mydecine Innovations Group and Green Thumb Industries, you can compare the effects of market volatilities on Mydecine Innovations and Green Thumb and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mydecine Innovations with a short position of Green Thumb. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mydecine Innovations and Green Thumb.

Diversification Opportunities for Mydecine Innovations and Green Thumb

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between Mydecine and Green is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Mydecine Innovations Group and Green Thumb Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Green Thumb Industries and Mydecine Innovations is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mydecine Innovations Group are associated (or correlated) with Green Thumb. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Green Thumb Industries has no effect on the direction of Mydecine Innovations i.e., Mydecine Innovations and Green Thumb go up and down completely randomly.

Pair Corralation between Mydecine Innovations and Green Thumb

Assuming the 90 days horizon Mydecine Innovations Group is expected to generate 14.29 times more return on investment than Green Thumb. However, Mydecine Innovations is 14.29 times more volatile than Green Thumb Industries. It trades about 0.1 of its potential returns per unit of risk. Green Thumb Industries is currently generating about 0.02 per unit of risk. If you would invest  45.00  in Mydecine Innovations Group on October 21, 2024 and sell it today you would lose (44.50) from holding Mydecine Innovations Group or give up 98.89% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Mydecine Innovations Group  vs.  Green Thumb Industries

 Performance 
       Timeline  
Mydecine Innovations 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Mydecine Innovations Group are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly uncertain basic indicators, Mydecine Innovations reported solid returns over the last few months and may actually be approaching a breakup point.
Green Thumb Industries 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Green Thumb Industries has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's forward indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Mydecine Innovations and Green Thumb Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Mydecine Innovations and Green Thumb

The main advantage of trading using opposite Mydecine Innovations and Green Thumb positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mydecine Innovations position performs unexpectedly, Green Thumb can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Green Thumb will offset losses from the drop in Green Thumb's long position.
The idea behind Mydecine Innovations Group and Green Thumb Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.

Other Complementary Tools

FinTech Suite
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.